{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T07:12:54Z","timestamp":1765609974921,"version":"build-2065373602"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Diagnostic Pathology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.anndiagpath.2020.151473","type":"journal-article","created":{"date-parts":[[2020,1,20]],"date-time":"2020-01-20T11:47:26Z","timestamp":1579520846000},"page":"151473","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Complete histopathologic examination of risk reduction gastrectomy specimens for CDH1 germline mutation: Is it warranted in routine clinical practice?"],"prefix":"10.1016","volume":"45","author":[{"given":"Qingzhao","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaohai","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dipti M.","family":"Karamchandani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.anndiagpath.2020.151473_bb0005","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1001\/jamaoncol.2016.5688","article-title":"Global, regional, and National Cancer Incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 Cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study","volume":"3","author":"Fitzmaurice","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.anndiagpath.2020.151473_bb0010","first-page":"7","article-title":"Cancer statistics, 2019","volume":"69","author":"Siegel","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.anndiagpath.2020.151473_bb0015","first-page":"1932","article-title":"P53 germline mutations in childhood cancers and cancer risk for carrier individuals","volume":"82","author":"Chompret","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1016\/j.anndiagpath.2020.151473_bb0020","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1097\/00000658-199302000-00002","article-title":"The impact of familial adenomatous polyposis on the tumorigenesis and mortality at the several organs. Its rational treatment","volume":"217","author":"Iwama","year":"1993","journal-title":"Ann Surg"},{"key":"10.1016\/j.anndiagpath.2020.151473_bb0025","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/S1470-2045(09)70041-5","article-title":"Management of extracolonic tumours in patients with Lynch syndrome","volume":"10","author":"Koornstra","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.anndiagpath.2020.151473_bb0030","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1002\/1097-0142(19920701)70:1<50::AID-CNCR2820700109>3.0.CO;2-I","article-title":"Family history and the risk of stomach and colorectal cancer","volume":"70","author":"La Vecchia","year":"1992","journal-title":"Cancer."},{"key":"10.1016\/j.anndiagpath.2020.151473_bb0035","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1007\/BF02253505","article-title":"Risk of gastric cancer among Korean familial adenomatous polyposis patients. Report of three cases","volume":"35","author":"Park","year":"1992","journal-title":"Dis. Colon Rectum"},{"key":"10.1016\/j.anndiagpath.2020.151473_bb0040","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/ajg.2009.725","article-title":"High cancer risk in Peutz-Jeghers syndrome: a systematic review and surveillance recommendations","volume":"105","author":"van Lier","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.anndiagpath.2020.151473_bb0045","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1002\/1097-0142(19901101)66:9<2047::AID-CNCR2820660934>3.0.CO;2-G","article-title":"Familial occurrence of gastric cancer in the 2-year experience of a population-based registry","volume":"66","author":"Zanghieri","year":"1990","journal-title":"Cancer."},{"key":"10.1016\/j.anndiagpath.2020.151473_bb0050","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/PAS.0b013e31815e7f1a","article-title":"Risk-reducing total gastrectomy for germline mutations in E-cadherin (CDH1): pathologic findings with clinical implications","volume":"32","author":"Rogers","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151473_bb0055","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/his.13715","article-title":"Pathological features of total gastrectomy specimens from asymptomatic hereditary diffuse gastric cancer patients and implications for clinical management","volume":"73","author":"Rocha","year":"2018","journal-title":"Histopathology."},{"key":"10.1016\/j.anndiagpath.2020.151473_bb0060","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1136\/jmg.36.12.873","article-title":"Familial gastric cancer: overview and guidelines for management","volume":"36","author":"Caldas","year":"1999","journal-title":"J Med Genet"},{"key":"10.1016\/j.anndiagpath.2020.151473_bb0065","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1053\/gast.2001.29611","article-title":"International Gastric Cancer Linkage Consortium. Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families","volume":"121","author":"Pharoah","year":"2001","journal-title":"Gastroenterology."},{"key":"10.1016\/j.anndiagpath.2020.151473_bb0070","series-title":"WHO classification of Tumours of the digestive system","first-page":"59","article-title":"Hereditary diffuse gastric cancer","author":"Carneiro","year":"2010"},{"key":"10.1016\/j.anndiagpath.2020.151473_bb0075","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.bpg.2006.03.013","article-title":"Familial gastric cancer - clinical management","volume":"20","author":"Fitzgerald","year":"2006","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/j.anndiagpath.2020.151473_bb0080","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1136\/jmedgenet-2015-103094","article-title":"Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers","volume":"52","author":"van der Post","year":"2015","journal-title":"J Med Genet"},{"key":"10.1016\/j.anndiagpath.2020.151473_bb0085","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1136\/jmg.2009.074237","article-title":"Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research","volume":"47","author":"Fitzgerald","year":"2010","journal-title":"J Med Genet"},{"key":"10.1016\/j.anndiagpath.2020.151473_bb0090","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0002-9440(10)65129-2","article-title":"Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation","volume":"155","author":"Keller","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151473_bb0095","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.3389\/fphar.2018.01421","article-title":"CDH1 gene and hereditary diffuse gastric cancer syndrome: molecular and histological alterations and implications for diagnosis and treatment","volume":"9","author":"Luo","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.anndiagpath.2020.151473_bb0100","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/01.sla.0000254370.29893.e4","article-title":"CDH1 truncating mutations in the E-cadherin gene: an indication for total gastrectomy to treat hereditary diffuse gastric cancer","volume":"245","author":"Norton","year":"2007","journal-title":"Ann Surg"},{"key":"10.1016\/j.anndiagpath.2020.151473_bb0105","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1097\/PAS.0b013e31826ca204","article-title":"Endoscopic surveillance of patients with hereditary diffuse gastric cancer- biopsy recommendations after topographic distribution of cancer foci in a series of 10 CDH1-mutated gastrectomies","volume":"36","author":"Fujita","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151473_bb0110","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.gie.2013.11.040","article-title":"Prospective cohort study assessing outcomes of patients from families fulfilling criteria for hereditary diffuse gastric cancer undergoing endoscopic surveillance","volume":"80","author":"Lim","year":"2014","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.anndiagpath.2020.151473_bb0115","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.gie.2017.06.028","article-title":"Comparative study of endoscopic surveillance in hereditary diffuse gastric cancer according to CDH1 mutation status","volume":"87","author":"EZ1","year":"2018","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.anndiagpath.2020.151473_bb0120","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/path.2415","article-title":"Histopathological and molecular analysis of gastrectomy specimens from hereditary diffuse gastric cancer patients has implications for endoscopic surveillance of individuals at risk","volume":"216","author":"Barber","year":"2008","journal-title":"J Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151473_bb0125","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1002\/path.1564","article-title":"Model of the early development of diffuse gastric cancer in E-cadherin mutation carriers and its implications for patient screening","volume":"203","author":"Carneiro","year":"2004","journal-title":"J Pathol"},{"key":"10.1016\/j.anndiagpath.2020.151473_bb0130","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1056\/NEJM200106213442504","article-title":"Early gastric cancer in young, asymptomatic carriers of germ-line E-cadherin mutations","volume":"344","author":"Huntsman","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.anndiagpath.2020.151473_bb0135","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1067\/msy.2001.117099","article-title":"Prophylactic total gastrectomy for familial gastric cancer","volume":"130","author":"Lewis","year":"2001","journal-title":"Surgery"},{"key":"10.1016\/j.anndiagpath.2020.151473_bb0140","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/1097-0142(20010701)92:1<181::AID-CNCR1307>3.0.CO;2-J","article-title":"Germline E-cadherin gene mutations: is prophylactic total gastrectomy indicated?","volume":"92","author":"Chun","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.anndiagpath.2020.151473_bb0145","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.cgh.2005.12.003","article-title":"Hereditary diffuse gastric cancer: diagnosis and management","volume":"4","author":"Blair","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.anndiagpath.2020.151473_bb0150","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1136\/gut.2002.010447","article-title":"Hereditary diffuse gastric cancer: predominance of multiple foci of signet ring cell carcinoma in distal stomach and transitional zone","volume":"53","author":"Charlton","year":"2004","journal-title":"Gut"},{"key":"10.1016\/j.anndiagpath.2020.151473_bb0155","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.surg.2010.07.005","article-title":"Prophylactic total gastrectomy for individuals with germline CDH1 mutation","volume":"149","author":"Pandalai","year":"2011","journal-title":"Surgery"},{"key":"10.1016\/j.anndiagpath.2020.151473_bb0160","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s10689-013-9698-8","article-title":"Prophylactic total gastrectomy in hereditary diffuse gastric cancer: identification of two novel CDH1 gene mutations-a clinical observational study","volume":"13","author":"Bardram","year":"2014","journal-title":"Fam Cancer"},{"key":"10.1016\/j.anndiagpath.2020.151473_bb0165","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/ijc.26398","article-title":"CDH1-related hereditary diffuse gastric cancer syndrome: clinical variations and implications for counseling","volume":"131","author":"Kluijt","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1016\/j.anndiagpath.2020.151473_bb0170","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1136\/jmg.2005.031385","article-title":"Cleft lip\/palate and CDH1\/E-cadherin mutations in families with hereditary diffuse gastric cancer","volume":"43","author":"Frebourg","year":"2006","journal-title":"J Med Genet"}],"container-title":["Annals of Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913420300149?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1092913420300149?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T20:31:17Z","timestamp":1761078677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1092913420300149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":34,"alternative-id":["S1092913420300149"],"URL":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2020.151473","relation":{},"ISSN":["1092-9134"],"issn-type":[{"type":"print","value":"1092-9134"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Complete histopathologic examination of risk reduction gastrectomy specimens for CDH1 germline mutation: Is it warranted in routine clinical practice?","name":"articletitle","label":"Article Title"},{"value":"Annals of Diagnostic Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anndiagpath.2020.151473","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"151473"}}